ClinVar Miner

Submissions for variant NM_004612.4(TGFBR1):c.1136T>C (p.Met379Thr)

dbSNP: rs886039004
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001046474 SCV000319595 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2023-04-05 criteria provided, single submitter clinical testing The p.M379T variant (also known as c.1136T>C), located in coding exon 7 of the TGFBR1 gene, results from a T to C substitution at nucleotide position 1136. The methionine at codon 379 is replaced by threonine, an amino acid with similar properties. This alteration has also been detected in multiple individuals in a thoracic aortic disease cohort (Jondeau G et al. Circ Cardiovasc Genet, 2016 Dec;9:548-558). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV001046474 SCV001210379 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2023-11-08 criteria provided, single submitter clinical testing This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 379 of the TGFBR1 protein (p.Met379Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Loeys Dietz syndrome and/or clinical features of Loeys-Dietz syndrome (PMID: 27879313; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 263993). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGFBR1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001764237 SCV001989937 uncertain significance not provided 2019-05-20 criteria provided, single submitter clinical testing Previously reported in individuals with thoracic aortic disease and a three generation family with Loeys-Dietz syndrome (Jondeau et al., 2016; Biggin et al., 2018); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported in ClinVar but additional evidence is not available (ClinVar Variant ID# 263993; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 29524015, 27879313)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.